Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat

European Journal of Pharmacology
G SperkO Hornykiewicz

Abstract

Levels of the putative neurotransmitters serotonin (5-HT) and dopamine (DA) and their respective metabolites 5-hydroxyindoleacetic acid (5-HIAA) and dihydroxyphenylacetic acid (DOPAC) was determined in the rat striatum after unilateral intrastriatal injection of the convulsive neurotoxin kainic acid. Two days after intrastriatal kainic acid injection, levels of the 5-HT metabolite 5-HIAA were increased by abut 200% in the injected striatum and by about 150% in the contralateral striatum. An elevated striatal 5-HIAA content was still detectable 10 days after the kainate lesion, but approached normal values 10 weeks after the injection of the neurotoxin. Two days after the lesion, but not at the other time intervals, a moderate increase of 5-HIAA also occurred bilaterally in other brain areas such as the substantia nigra, frontal cortex and hypothalamus. Levels of 5-HT were decreased significantly in the injected striatum 2 days after the intrastriatal application of kainic acid and increased by about 40% after 10 weeks. The 5-HT concentration in the contralateral striatum or in the three other brain areas examined was unchanged at all time intervals. Levels of the DA metabolite DOPAC and DA turnover were increased in the lesione...Continue Reading

References

May 27, 1977·Brain Research·R Schwarcz, J T Coyle
Sep 8, 1978·Brain Research·R ZaczekJ T Coyle
Jun 12, 1978·Annals of the New York Academy of Sciences·G JonssonC Sachs
Jun 22, 1979·Science·S T Mason, H C Fibiger
Jun 30, 1978·Brain Research·S M WuertheleK E Moore
Sep 21, 1978·Nature·T A James, M S Starr
Nov 15, 1976·Life Sciences·L M Neckers, J L Meek
Dec 17, 1976·Brain Research·E G McGeerP L McGeer
Oct 20, 1980·Life Sciences·S C Gerson, R J Baldessarini
Feb 1, 1963·Biochemical Pharmacology·E ROBERTS, D G SIMONSEN

❮ Previous
Next ❯

Citations

Aug 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·L PichlerW Kobinger
Jun 15, 1983·Klinische Wochenschrift·H HörtnaglW Druml
Sep 22, 1987·Brain Research·K KamataY Kasuya
Nov 13, 1984·European Journal of Pharmacology·H HörtnaglW Kobinger
Jul 17, 1985·European Journal of Pharmacology·H BaranO Hornykiewicz
Apr 1, 1989·Journal of Neuroscience Methods·M L BergerH Lassmann
Jan 1, 1994·Progress in Neurobiology·G Sperk
May 5, 2005·Brain Research·Jörg-Peter VoigtHeidrun Fink
May 21, 1998·Neuroscience Research·M J RiddP Fosbraey
Jan 14, 1998·Brain Research. Molecular Brain Research·K TsunashimaR Fischer-Colbrie
Jan 15, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Eduardo A SchilmanDaphna Joel
Jun 13, 2009·Proceedings of the National Academy of Sciences of the United States of America·Natalia AleninaMichael Bader
Jul 11, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Golo KronenbergMatthias Endres
Dec 31, 2011·European Journal of Pharmacology·Olaf Schulte-HerbrüggenRainer Hellweg
Apr 17, 2008·The European Journal of Neuroscience·Christine WinterDaphna Joel
Aug 28, 1989·Brain Research·H BaranO Hornykiewicz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.